A monoclonal antibody, 5H4, that recognizes human herpesvirus 7 (HHV-7) was used in Western analysis to probe HHV-7-infected SupT1 cells. This antibody recognizes a 40-kDa virus-specific polypeptide that is expressed in the absence of viral DNA synthesis. By screening a gt11 HHV-7 cDNA library, the gene encoding the protein was identified as the U27 open reading frame previously reported [J. Virol. (1996) 70, 5975-5989]. Immunofluorescent studies showed a punctate nuclear localization of the protein in both HHV-7-infected cells and transfected cells. A computer program predicted two classic nuclear localization signals (NLSs) in the middle and C-terminal regions of the protein. A C-terminal deletion mutant of the protein could not enter the nucleus, whereas green fluorescent protein or maltose binding protein fused to the C-terminal region of the protein was transported into the nucleus. These findings demonstrate that the predicted C-terminal, but not middle, NLS of the protein actually function as NLS. In addition, nuclear transport of a maltose binding protein-fusion protein containing the C-terminal NLS of the U27 protein was inhibited by both wheat germ agglutinin and a Q69L Ran-GTP mutant, indicating that the U27 protein is transported into the nucleus from the cytoplasm by means of classic nuclear transport machinery. Interestingly, this NLS motif is highly conserved at the C-termini of all herpesvirus DNA polymerase processivity factors that have been examined.
INTRODUCTION
Human herpesvirus 7 (HHV-7) is an ubiquitous, T lymphotropic ␤-herpesvirus that was first isolated in 1990 from CD4 ϩ lymphocytes of a healthy adult (Frenkel et al., 1990) . Seroepidemiological studies have indicated that the primary infection with HHV-7 occurs early in childhood, although the age of infection with HHV-7 appears to be somewhat later than that with HHV-6, and that HHV-7 is another causative agent of exanthem subitum, a common childhood disease (Tanaka et al., 1994; Tanaka-Taya et al., 1996; Wyatt et al., 1991) . Molecular biological and immunological studies have demonstrated that HHV-7 belongs to the ␤-herpesvirus family and that HHV-6 is the most closely related virus to HHV-7 of the members of this family, but nevertheless they differ from each other significantly (Berneman et al., 1992; Foa-Tomasi et al., 1994; Nakagawa et al., 1997; Nicholas 1996; Wyatt et al., 1991) .
Among herpesviruses, DNA polymerase processivity factors are highly conserved (Gompels et al., 1995; Nicholas, 1996; Russo et al., 1996) and have been shown to be essential for viral DNA replication (Gao et al., 1993; Johnson et al., 1991; Ripalti et al., 1995) . A DNA polymerase processivity factor forms a complex with its viral DNA polymerase and increases the activity of the polymerase (Digard et al., 1993; Weiland et al., 1994) , as do the proliferating cell nuclear antigen of yeast, the ␤ subunit of Escherichia coli DNA polymerase III holoenzyme, and gene product 45 of T4 phage (Kuriyan and O'Donnell, 1993) . However, the structure of these enzymes and the mechanism by which they confer processivity on their polymerase remain unclear. So far, it has been demonstrated that the C-terminal region of DNA polymerase processivity factor is dispensable for binding to and activating DNA polymerase in vitro and in vivo (Digard et al., 1993; Gao et al., 1993; Tenny et al., 1993; Weiland et al., 1994) .
In this report, we characterize the general features (molecular weight, time course of expression, localization in infected cells) of the HHV-7 U27 protein, a homolog of herpesvirus DNA polymerase processivity factor, and present compelling evidence that the extreme C-terminal region of the protein functions as a Randependent nuclear localization signal.
RESULTS AND DISCUSSION
Identification of HHV-7 cDNA clones that react with the 5H4 monoclonal antibody A series of monoclonal antibodies were established against HHV-7 for use in studying viral proteins. In this study, one of them, 5H4, was characterized by the following experiments.
First, to identify the gene encoding the protein recognized by the 5H4 monoclonal antibody, a gt11 HHV-7 cDNA expression library was constructed. On screening, several immunoreactive clones were recognized, and the inserted cDNAs were amplified by PCR and cloned into a plasmid vector, pCRII (Invitrogen, San Diego, CA). Determination of their DNA sequences revealed that cloned cDNAs contained the U27 open reading frame (ORF), which encodes for a homolog of herpesvirus DNA polymerase processivity factor (Nicholas, 1996) .
Expression of the U27 ORF
To investigate the size of the U27 protein, HHV-7-infected SupT1 cell proteins were analyzed by Western blotting using the monoclonal antibody 5H4 as a probe. As shown in Fig. 1A , a polypeptide with an apparent molecular mass of 40 kDa was detected in HHV-7-infected cells (lane 1) but not in uninfected cells (lane 2). The size of this protein is in agreement with the predicted size (41.6 kDa) of the protein encoded by the U27 ORF. Immunoprecipitation analysis of the protein prepared from HHV-7-infected cells also showed a virusspecific 40-kDa protein (data not shown).
The time course of the U27 protein expression was examined by Western analysis of HHV-7-infected SupT1 cell lysates prepared at different times after infection. As shown in Fig. 1B , the U27 protein was first detectable at 24 h postinfection (p.i). In comparison, a tegument protein was first detectable at 48 h p.i with the monoclonal antibody 24G7, which is specific for HHV-7 U14 protein (Stefan et al., 1997) . The expression of U27 earlier in infection than the viral tegument protein is consistent with the predicted role of the U27 protein in viral DNA replication.
To study the synthesis of the U27 protein with respect to the replicative cycle of HHV-7, Western blotting using 5H4 was performed on HHV-7-infected SupT1 cell lysates exposed to a potent viral replication inhibitor, phosphonoformic acid (PFA). As shown in Fig. 1C , the expression of U27 was detectable even in the presence of PFA, but the expression of the tegument protein (U14 product) was completely inhibited by PFA. This result indicates that the expression of the U27 protein, but not the U14 protein, is independent of the viral DNA synthesis.
Next, to determine the intracellular distribution of U27, proteins from HHV-7-infected cells were separated into nuclear and cytoplasmic fractions, as described in Materials and Methods, and analyzed by Western blotting using the monoclonal antibody 5H4 and anti-HSP90␤. The U27 protein was detected only in the nuclear fraction (Fig. 1D, left) , suggesting that it is predominantly localized to the nucleus of HHV-7-infected cells, which is in agreement with its predicted role in viral DNA replication. On the other hand, almost all of the HSP90␤, a cytoplasmic marker, was detected in the cytoplasmic fraction, indicating that the cell extracts were successfully fractionated (Fig. 1D, right) .
Localization of the U27 protein in HHV-7-infected or transfected cells
For further characterization of the subcellular localization of the U27 protein, its expression was investigated by indirect immunofluorescence using 5H4. As shown in Fig. 2A , the nuclei of HHV-7-infected SupT1 cells exhibited a strong punctate pattern (panel a) as previously described for HHV-6 (Agulnick et al., 1993) . Interestingly, 5H4 reacted not only with HHV-7-infected SupT1 but also with HHV-6-infected MT-4 cells ( Fig. 2A, panels a and b) . On the other hand, the control monoclonal antibody OHV3, which recognizes gH of HHV-6B (Okuno et al., 1990; Takeda et al., 1997) , reacted only with MT-4 cells infected with HHV-6B ( Fig. 2A , panels e and f). The specificity of the primary and secondary antibodies was evident by the absence of reactivity to uninfected cells ( Fig. 2A, panels c and d) . Cross-reactions of anti-HHV-7 monoclonal antibodies with HHV-6 have been previously reported (Berneman et al., 1992; Foa-Tomasi et al., 1994; Nakagawa et al., 1997; Wyatt et al., 1991) .
COS7 cells were also transfected with a plasmid, pcDNA/7U27, capable of expressing a full-length U27 protein, and 48 h later, U27 protein and the nuclei were stained with the monoclonal antibody 5H4 and Hoechst 33258, respectively. As shown in Fig. 2B , U27 localized to the nucleus of transiently transfected cells and the nucleoli were not stained; these results were the same as previously reported for HHV-6 (Agulnick et al., 1993) . This result is consistent with the results of the fractionation experiment ( Fig. 1D ) and of the immunofluorescent assay (IFA) of HHV-7-infected SupT1 cells ( Fig. 2A) . The immunofluorescent result from the transfected COS7 cells also revealed that nuclear translocation of U27 protein occurred in the absence of other viral proteins. However, there was a striking difference between the expression patterns of U27 protein in virally infected SupT1 cells and transiently transfected COS7 cells (Figs. 2A and 2B) , although confocal microscopy analysis showed a granular nuclear localization of the U27 protein in the transiently transfected cells (data not shown). The expression pattern of U27 protein may depend on the absence or the presence of other viral proteins, which form a replication compartments, or the cell type where it was expressed.
Prediction of a nuclear localization signal
Because the nuclear localization of U27 (Fig. 2B) suggested that U27 contains a nuclear localization signal (NLS) in its amino acid sequence, we used a computer program (PSORT II, http://nibb.ac.jp:8000/) to search the U27 sequence for putative NLSs. The computer program was able to predict two putative classic NLSs (type pat7) in the U27 protein (Fig. 3A) . These NLS sequences start with proline, which is followed within three residues by a basic segment where three of the next four residues are lysines or arginines. One NLS was predicted to reside between residues 176 and 182 (PVTKNKR); another is present in the extreme C-terminal domain (residues 355-361, PNSKRQR). In addition, the amino acid sequence alignment of the HHV-7, HHV-6, and HCMV DNA polymerase processivity factor homologs showed that the two putative NLSs are conserved among these human ␤-herpesviruses (Fig. 3A) . Interestingly, a strong casein kinase II phosphorylation site was also found upstream of the C-terminal NLS of these herpesviruses (Fig. 3A) , suggesting that phosphorylation of this site may affect nuclear translocation of the protein, as previously described (Rihs et al., 1991) . Furthermore, this classic NLS motif was conserved at the extreme C-termini of all of the other herpesvirus DNA polymerase processivity factors that were examined (Fig. 3B) .
Mapping of the NLS activity of U27 protein
To determine whether one or both of the U27 NLSs were functional, we constructed a C-terminal deletion mutant of the U27 protein (Fig. 4A) , which lacked the C-terminal NLS sequence. Because the monoclonal antibody 5H4 could not detect the C-terminal deletion mutant (data not shown), an His-Xpress epitope sequence was added at the N-terminus of the protein for detection with the anti-Xpress antibody (Invitrogen). The HisXpress epitope-tagged full-length U27 protein, from the plasmid pHis/7U27, localized to the cell nucleus, as did U27 protein alone (Fig. 4B, panels b and a, respectively) . Thus epitope tagging dose not alter the distribution of the protein in transiently transfected cells. The C-terminal deletion mutant with its epitope tag, His/U27(1-250), did not accumulate in the nucleus (Fig. 4B, panel c) , indicating that the C-terminal region of U27 is required for the translocation of the protein from the cytoplasm to the nucleus. On the other hand, one of the two predicted NLSs was present in the deletion mutant (Fig. 3A , residues 176-182) and did not function as an NLS, although it was conserved among human ␤-herpesviruses. To confirm the NLS activity of the C-terminal region of U27, we expressed a green fluorescent protein (GFP)-fusion protein fused to the C-terminal region of U27 protein, corresponding to amino acid residues 251-364, in transfected cells. As shown in Fig. 4B , the GFP-fusion protein completely localized to the nucleus (panel e), whereas GFP alone was observed in both the nucleus and cytoplasm (panel d). These findings demonstrate that the C-terminal region of U27 protein contains a functional NLS.
To further characterize the C-terminal domain containing the NLS, various C-terminal regions of U27 protein were expressed as GFP-fusion proteins in transfected cells, and the distributions of the proteins were analyzed. GFP/ 7U27(251-364), GFP/7U27(276-364), and GFP/7U27(301-364) localized to the nucleus (Fig. 4B , panels e-g, respectively). Cytoplasmic localization was observed in the case of GFP/7U27(326-364) and GFP/7U27(351-364), although intense nuclear fluorescence was also detected (panels h and i). These data suggest that the last 14-amino-acid stretch of U27 protein is required for the nuclear localization in vivo. Recently, Epstein-Barr virus DNA polymerase processivity factor encoded by BMRF1 was shown to contain an NLS in the last 26 amino acids (Zhang et al., 1999) . Gao et al. (1993) reported that HSV-1 mutant deleted for the C-terminal third of the DNA polymerase processivity factor, including the C-terminal NLS, replicated similarly to the wild-type virus in cultured cells. Although the C-terminal region of DNA polymerase processivity factor of HSV-1 is dispensable in cultured cells, its function in infected individuals remains unknown. Because the number of NLSs correlated with the relative uptake of conjugates with NLSs into the nucleus (Dworetzky et al., 1988) , the C-terminal NLS may be required for the efficient viral replication in infected individuals. In addition, it was recently reported that EBV DNA polymerase processivity factor functioned as a transactivator and that the C-terminal part of the protein was required for the transactivation (Zhang et al., 1999) .
Wheat germ agglutinin and Q68L Ran-GTP mutant inhibit nuclear transport via the NLS
To exclude the possibility that GFP fusion protein with the C-terminal region of U27 entered the cell nucleus by passive diffusion, we examined whether wheat germ agglutinin (WGA) blocked nuclear localization. WGA selectively inhibits the active nuclear transport of proteins by binding to a component of the nuclear pore complex (NPC) but does not block nuclear translocation of small molecules by passive diffusion (Finlay et al., 1987; Yoneda et al., 1987) . We constructed a fusion protein with maltose binding protein (MBP) fused in-frame with the C-terminal region of U27, containing the sequence between amino acids 251 and 364 (Fig. 4A) . The purified fusion protein was microinjected into the cytoplasm of HeLa cells in the absence or presence of WGA. As shown in Fig. 4B (panel k) , the microinjected MBP-fusion protein, MBP/7U27(251-364), translocated into the nucleus, but the protein did not enter the nucleus in the presence of WGA (panel l). MBP alone was not localized to the nucleus, probably because of its molecular size (51 kDa) and the absence of an NLS (panel j). These findings indicate that MBP-fusion protein was transported to the nucleus through the NPC and confirm that the C-terminal region of U27 protein is responsible for its nuclear translocation.
The Ran protein has been shown to be required for classic NLS-dependent nuclear transport (Moore and Blobel, 1993) . To determine whether Ran is required for the nuclear transport of the HHV-7 U27 protein, we microinjected both the MBP/7U27(251-364)-fusion protein and a mutated Ran protein, Q69L Ran-GTP, which is deficient in GTP hydrolysis (Palacios et al., 1996) , into the cytoplasm of HeLa cells and immunochemically assessed the expression pattern of MBP/7U27(251-364). As shown in Fig. 4B (panel m) , MBP/7U27(251-364) did not enter the nucleus in the microinjected cells. This result demonstrates that the nuclear translocation of U27 via the NLS is Ran dependent and requires the hydrolysis of GTP.
In summary, we found that HHV-7 U27 is a 40-kDa nuclear protein that is synthesized in the absence of viral DNA synthesis. We mapped the functional NLS of U27 to the extreme C-terminus of the protein and showed its activity to be dependent on Ran. Interestingly, a similar NLS motif is conserved at the C-termini of the other herpesvirus DNA polymerase processivity factors that we tested.
MATERIALS AND METHODS

Viruses and cells
HHV-7 (strain KHR) and HHV-6 (strain HST) were propagated in SupT1 and MT-4 continuous T-cell lines, respectively. Both cell lines were cultured in RPMI 1640 medium containing 10% heat-inactivated fetal calf serum (FCS). COS7 and HeLa cells were grown in Dulbecco's modified Eagle's medium (DMEM) supplemented with 10% or 5% FCS.
Antibodies
Hybridoma clones producing anti-HHV-7 monoclonal antibodies were established from splenocytes of mice immunized with KHR-infected SupT1 cells as described previously (Nakagawa et al., 1997) . The monoclonal antibodies 5H4 and 24G7 recognize the U27 and U14 proteins of HHV-7, respectively. The monoclonal antibodies anti-Xpress and anti-HSP90␤ and the rabbit anti-MBP antiserum were purchased from Invitrogen, Santa Cruz (Santa Cruz, CA), and New England Biolabs (Beverly, MA), respectively.
Construction and screening of cDNA library
Polyadenylated RNA was isolated from HHV-7-infected SupT1 cells using the Fast-Track system (Invitrogen), reverse transcribed with the Superscript Choice System (GIBCO BRL, Grand Island, NY), and then used to generate a gt11 cDNA library. This library was screened with the 5H4 monoclonal antibody using picoBlue immunoscreening kit (Stratagene, La Jolla, CA), and several positive plaques were identified. The HHV-7 cDNA insert in the lambda DNA was amplified by PCR, and the amplified products were cloned into the pCRII (Invitrogen), TA-cloning vector, and sequenced by the dideoxynucleotide chain termination method.
IFA
For HHV-7-and HHV-6-infected cells, indirect IFA was performed as described previously (Takeda et al., 1996) .
For HeLa cells microinjected with the MBP-fusion pro-
FIG. 4. (A)
Construction of expression plasmids for the full-length HHV-7 U27 protein, the C-terminal deletion mutant, and the in-frame fusion of GFP and MBP with the C-terminal region of HHV-7 U27. PCR products, encoding the full-length, N-terminal, and C-terminal regions of HHV-7 U27, were cloned into an expression vector, pcDNA/3.1(ϩ), pcDNA3.1/His C, pEGFP-C1, or pMAL-c2 as described in tein, cells were washed with PBS, fixed with 3.7% formaldehyde in transport buffer (20 mM HEPES, pH 7.4, 110 mM potassium acetate, 2 mM magnesium acetate, 5 mM sodium acetate, 0.5 mM EGTA) for 10 min at room temperature (R.T.), and permeabilized with 0.5% Triton X-100 in PBS for 5 min at R.T. Cells were incubated in blocking buffer (3% skim milk in PBS) for 20 min at R.T. and then reacted with anti-MBP rabbit serum in blocking buffer. After washing with PBS three times for 5 min each, cells were incubated in blocking buffer supplemented with cy3-labeled anti-rabbit IgG antibodies for 30 min at R.T. After washing as above, cells were observed using fluorescence microscopy.
For COS7 cells transfected with the GFP-fusion plasmid, cells were observed directly using a fluorescence microscope.
Western blot analysis
Protein samples were fractionated by SDS-PAGE and electrophoretically transferred to a polyvinylidene difluoride (PVDF) membrane (BioRad, Hercules, CA). The membrane was incubated in blocking buffer (0.05% Tween 20, 5% skim milk in TBS) for 1 h with shaking at R.T. to block the nonspecific binding sites. Primary antibody incubation was carried out for 1 h at R.T. with shaking in antibody dilution buffer (0.05% Tween 20, 2% skim milk in TBS) with 1:500 dilution of monoclonal antibody. After washing (0.05% Tween 20 in TBS) three times for 10 min each, the membrane was finally incubated for 1 h as above with 1:2000 dilution of alkaline phosphatase-conjugated goat anti-mouse antibodies (BioRad). After washing as above, bound enzyme-labeled antibodies were detected with 5-bromo-4-chloro-3-indolyl-phosphate (BCIP) and nitroblue tetrazolium (NBT) substrate (Wako Bioproducts, Richmond, VA).
Time course of U27 protein expression
SupT1 cells (5 ϫ 10 6 ) were infected with 10 3 tissue culture infectious dose 50 (TCID 50 ) of HHV-7 and then cultured in RPMI 1640 supplemented with 5% FCS. At 0, 24, 48, 72, and 96 h after infection, infected cells were collected, washed with PBS, and lysed in a sample buffer (0.1 M Tris-HCl, pH 6.8, 20% glycerol, 4% SDS, 5% ␤-mercaptoethanol, 0.2% bromphenal blue). After SDS-PAGE, followed by transfer to PVDF membrane, the time course of protein expression was determined by Western blot analysis.
HHV-7 antigen expression in the presence of PFA SupT1 cells were pretreated with PFA (500 g/ml) for 1 h before infection or left untreated and then infected with HHV-7. Infected cells were cultured in RPMI 1640 medium supplemented with 5% FCS in the presence or absence of PFA for 72 h in a CO 2 incubator. After separation of infected cell proteins by SDS-PAGE, Western blotting was performed.
Preparation of nuclear and cytoplasmic fractions
Nuclear and cytoplasmic fractions were prepared as described previously (Schreiber et al., 1989) . Briefly, HHV-7-infected SupT1 cells were washed with PBS and resuspended in cold buffer A (10 mM HEPES, pH 7.9, 10 mM KCl, 0.1 mM EDTA, 0.1 mM EGTA, 1 mM DTT), and then Nonidet P-40 was added. After incubation for 15 min on ice, the nuclear fraction was pelleted by centrifugation at 12,000 g for 30 s. The supernatant was used as the cytoplasmic fraction.
Construction of HHV-7 U27 expression plasmids
The DNA fragment encoding the full-length HHV-7 U27 protein was amplified by PCR using primers 7U27-F1 and 7U27-R1. The viral DNA from strain KHR was used as the template for PCR. The sequences of the above primers were as follows: for 7U27-F1, 5Ј-CAGGATCCATCTATTTT-TGGTGCAGCATGG; and for 7U27-R1, 5Ј-CAGAATTCCT-TATGATTACATTCCACATCTTTG. The amplified fragment was digested with BamHI and EcoRI and then inserted into pcDNA3.1(ϩ) (Invitrogen) to create the plasmid pcDNA/7U27. The cloned DNA sequence was confirmed by sequencing using the dideoxy chain-termination method. The nucleotide sequence of strain KHR U27 was completely identical to that published for strain JI (Nicholas, 1996) .
To construct an expression plasmid for the His-Xpress epitope-tagged C-terminal deletion mutant of the HHV-7 U27 protein, the DNA fragment was amplified by PCR using the primers 7U27-F1 and 7U27-R4 (5Ј-CAGAAT-TCTTAACACGAAGACTTTAAAACTGC). Amplified DNA fragments were digested with BamHI and EcoRI and cloned into pcDNA3.1/HisC (Invitrogen). The resulting plasmid, pHis/7U27(1-250), expresses the amino acid sequence of HHV-7 U27 between residues 1 and 250. For the expression of the His-Xpress epitope-tagged fulllength U27 protein, the DNA fragment from the plasmid pcDNA/7U27 was recloned into the vector, pcDNA3.1/ HisC, yielding the plasmid pHis/7U27.
To construct plasmids pGFP/7U27(251-364), pGFP/ 7U27(276-364), pGFP/7U27(301-364), pGFP/7U27(326-364), and pGFP/7U27(351-364), various regions of HHV-7 U27 were amplified by PCR, digested with EcoRI and BamHI, and then ligated into the expression vector, pEGFP-C1 (Clontech, Palo Alto, CA). As forward primers, 7U27-F2 (5Ј-CAGAATTCTAGTCTTAGAGCAATAGCTGGC), 7U27-F3 (5Ј-CAGAATTCTTATTTAAGTCAAGAGCAG-GTTAAAG), 7U27-F4 (5Ј-CAGAATTCTAATCACAAGGTG-GAGGAAGGA), 7U27-F5 (5Ј-CAGAATTCTCCCACTA-AAAATGGTGGCACAG), and 7U27-F6 (5Ј-CAGAAT-TCTTTTGACTATACCCCAAATTCGAAAAG) were used, respectively. 7U27-R6 (5Ј-CAGGATCCTGTATCGCTGAA-GACACATGGC) was used as a common reverse primer.
To express the MBP fused to the C-terminus of the HHV-7 U27 protein, the plasmid pMAL/7U27(251-364) was constructed. Briefly, the DNA fragment encoding amino acids 251-364 of the HHV-7 U27 protein was amplified by PCR using primers MAL7U27-F and MAL7U27-R. The amplified DNA fragment was digested with EcoRI and PstI and then cloned into the plasmid pMAL-c2 (New England Biolabs). The sequences of the primers were 5Ј-CAGAATTCAGTCTTAGAGCAATAGCT-GGC for MAL7U27-F and 5Ј-CACTGCAGTGTATCGCT-GAAGACACATGGC for MAL7U27-R.
Microinjection
HeLa cells were grown onto glass coverslips in DMEM supplemented with 5% FCS. Purified MBP-or MBP/7U27(251-364)-fusion protein (2 mg/ml) was microinjected into the cell cytoplasm. After a 1-h incubation in a CO 2 incubator, cells were fixed in 3.7% formaldehyde, permeabilized in 0.5% Triton X-100 in PBS, and then used for IFA with anti-MBP antiserum (New England Biolabs). For the experiments examining the inhibition of nuclear translocation, WGA (2 mg/ml) or the Q69L Ran-GTP mutant (4 mg/ml) was comicroinjected with the MBP-fusion protein into the cell cytoplasm. MBP and the MBP-fusion protein were purified using Amylose resin (New England Biolabs) according to the instruction manual.
